(Q37254197)

19 August 2017

Multiple psychiatric diagnoses common in privately insured children on atypical antipsychotics (English)

1 reference

19 August 2017

Donna R Halloran

1

1 reference

19 August 2017

Jason Swindle

series ordinal

2

1 reference

19 August 2017

Steve K Takemoto

series ordinal

3

1 reference

19 August 2017

Mark A Schnitzler

series ordinal

4

1 reference

19 August 2017

28 January 2010

1 reference

19 August 2017

1 reference

19 August 2017

49

1 reference

19 August 2017

5

1 reference

19 August 2017

485-490

1 reference

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Psychotropic medication patterns among youth in foster care

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Aripiprazole: in adolescents with schizophrenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Use of antipsychotics in children and adolescents.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Second-generation antipsychotic medications in children and adolescents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

New users of antipsychotic medications among children enrolled in TennCare

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Concomitant psychotropic medication for youths

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Drug treatment of conduct disorder in young people

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Risperidone in children with autism and serious behavioral problems

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Treatment with atypical antipsychotics: new indications and new populations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Body mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Diagnoses and antipsychotic treatment among youths in a public mental health system

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

A 26-week open-label study of quetiapine in children with conduct disorder

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Transient ischemic attack with risperidone and clonidine

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Olanzapine versus placebo in the treatment of adolescents with bipolar mania

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Risperidone in children with autism: randomized, placebo-controlled, double-blind study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Prevalence of atypical antipsychotic drug use among commercially insured youths in the United States.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Multiple psychotropic medication use for youths: a two-state comparison.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

A retrospective analysis of the short-term effects of olanzapine and quetiapine on weight and body mass index in children and adolescents

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Geographic Disparities in Children’s Mental Health Care

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Datapoints: use of multiple psychotropic drugs by Medicaid-insured and privately insured children.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3807865

Trends in the Use of Typical and Atypical Antipsychotics in Children and Adolescents

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F0009922809347369

Olanzapine for the treatment of bipolar disorder in children and adolescents

21 January 2018

1 reference

12 December 2020

Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid ADHD, conduct/oppositional-defiant disorder, and aggression: a prospective, open-label study

1 reference

12 December 2020

Combined pharmacotherapy for TS and OCD

1 reference

12 December 2020

Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder

1 reference

12 December 2020

Trends in prescribing of antipsychotic medications for US children

1 reference

12 December 2020

Methamphetamine and fluoxetine treatment of a child with attention-deficit hyperactivity disorder and obsessive-compulsive disorder

1 reference

12 December 2020

Tardive dyskinesia in children treated with atypical antipsychotic medications

1 reference

12 December 2020

Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents

1 reference

12 December 2020

Psychotropic prescriptions in a sample including both healthy and mood and disruptive disordered preschoolers: relationships to diagnosis, impairment, prescriber type, and assessment methods

1 reference

12 December 2020

Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder

1 reference

12 December 2020

Identifiers

DOI

10.1177/0009922809347369

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

20118088

1 reference